1st Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$920,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings Funding of Comprehensive Addiction and Recovery Act FY17 Appropriations FY18 Appropriations Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)

LobbyistCovered position, as disclosed
ROBERT FORMAN —
MEGAN JACKSON New Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN —
ABIGAIL PINKELE New Legislative Director for Rep. Gene Green from 2003-2012

Contacted: Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; SENATE; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Veterans Affairs, Dept of (VA)

Pharmacy PHA

Public law #114-198, Cures Opioid Funding Implementation Reauthorization of the Prescription Drug User Fee Act (PDUFA)

LobbyistCovered position, as disclosed
ROBERT FORMAN —
MEGAN JACKSON New Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN —
ABIGAIL PINKELE New Legislative Director for Rep. Gene Green from 2003-2012

Contacted: Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness

LobbyistCovered position, as disclosed
ROBERT FORMAN —
MEGAN JACKSON New Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN —
ABIGAIL PINKELE New Legislative Director for Rep. Gene Green from 2003-2012

Contacted: Justice, Dept of (DOJ); Veterans Affairs, Dept of (VA); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1682 (115th)

Medicare/Medicaid MMM

Maintain Medicare's six protected class for depression and schizophrenia S. 648, Medicare Formulary Improvement Act of 2015

LobbyistCovered position, as disclosed
ROBERT FORMAN —
MEGAN JACKSON New Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN —
ABIGAIL PINKELE New Legislative Director for Rep. Gene Green from 2003-2012

Contacted: HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); Veterans Affairs, Dept of (VA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Bills named: S. 648 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.